OnCuRNA Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

OnCuRNA General Information

Description

Developer of a nanohydrogel drug delivery platform designed for the treatment of solid tumors. The company's technology utilizes a proprietary nanohydrogel system that enhances the delivery of therapeutic payloads to solid tumors, providing control over drug release, targeting, and efficacy, enabling the oncology market to achieve precise delivery of therapies while minimizing systemic toxicities.

Contact Information

Website
www.oncurna.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • PO Box 19124
  • Atlanta, GA 31126
  • United States
+1 (706)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Corporate Office
  • PO Box 19124
  • Atlanta, GA 31126
  • United States
+1 (706)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OnCuRNA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 24-Jun-2025 Completed Pre-Clinical Trials
1. Early Stage VC 01-Sep-2024 Completed Pre-Clinical Trials
To view OnCuRNA’s complete valuation and funding history, request access »

OnCuRNA Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biolocity Accelerator/Incubator
Georgia Research Alliance Not-For-Profit Venture Capital Minority
To view OnCuRNA’s complete investors history, request access »

OnCuRNA FAQs

  • When was OnCuRNA founded?

    OnCuRNA was founded in 2021.

  • Where is OnCuRNA headquartered?

    OnCuRNA is headquartered in Atlanta, GA.

  • What industry is OnCuRNA in?

    OnCuRNA’s primary industry is Drug Discovery.

  • Is OnCuRNA a private or public company?

    OnCuRNA is a Private company.

  • What is OnCuRNA’s current revenue?

    The current revenue for OnCuRNA is .

  • Who are OnCuRNA’s investors?

    Biolocity and Georgia Research Alliance have invested in OnCuRNA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process